ACL surgery recovery boost? new trial tests One-Dose Anti-Inflammatory drug
NCT ID NCT07332910
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a single dose of tranexamic acid (TXA), given during ACL reconstruction surgery, can reduce inflammation and improve early recovery. Sixty adults having ACL surgery will be randomly assigned to receive either TXA or a placebo. The main goal is to measure changes in a key inflammatory marker (IL-6) over the first 24 hours after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACL RECONSTRUCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chirec Delta
Brussels, 1160, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Osteoporosis drug could strengthen knee rebuilds
- Blood flow cuffs or instrument massage: which boosts ACL recovery best?
- Could a simple steroid taper cut opioid use after ACL surgery?
- Simple hop test could predict ACL Re-Injury risk
- Can adding motion release to blood flow training boost ACL healing?
- Does an extra knee ligament procedure lead to arthritis later?